Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Didn't $IQST management indicate in a press release that they anticipated going to the next level in December 2021? Now they have provided indication of an intention to continue M&A activity to further increase expected telcom 2022 revenue. Could this indicate that the next level being referred to is $100 million+ in telcom revenue via ongoing M&A awaiting due diligence for the next MOU? If so was the Smartbiz llc MOU the entree' or the appetizer?
Did blockchain & MNPA upselling data generated during October & early November influence SmartBiz LLC's willingness to enter into the #MOU? IF so, does the #MOU become an indicator for $IQST exceeding $6 million in preliminary revenue for the month of October? Such success could easily lead to an immediate doubling of share price.
MA expenses were 957,195 for the 3rd quarter or $10,635/day. IF September 2021 preliminary revenue less cost of revenue generates a gross profit of 10,666/day, then daily cost of $IQST business activities reached Break Even by the end of September & began shading net profitability.
Their latest tweet, therefore, is mostly accurate when translating reached break even during Q3 as to reach during Q3
On a quarterly basis, the cost of revenue is $175,000/ day. if they are currently making $185,000 per day since September 30th, 2021 $IQST is profiting $10,000/ day. We are on day 47, so that is a current projected Q4 profit of $470,000 today that will total $900,000 on December 31st, 2021 assuming that their customer base remains constant since September 30th.
All things only being equal, FY22 profit will be $3.65 million.
How much preliminary revenue for October 2021 will IQST have to announce in order for the market to believe it is firmly profitable as established by the reported exactingly controlled cost of revenue in the Q3 report (declined by $408,000 from Q2 on $388,000 revenue gain in Q3) ? July rev= $5.23m, August Rev= 5.7m, September Rev=$5.57, October Revenue= ?
profit= +/-?
The difference in revenue for August & September is $113,000 differentiated by August having 31 days with avg daily rev of $183,870 & September 30 days with avg daily rev of 185, 666.
Tea leaf math suggests October Rev will be at least 5.75m
If we include july rev of 5.23/ 31 days = $168,709 daily rev avg we can prognosticate a consistently growing customer base
GPS, Sirius, other apps, bluetooth, smartphone integration (hotspot) & notifications..........
Is Ago National Bank the expected MA target? @Vimo_vip
1) I don't mind short selling at higher prices. It provides trading liquidity for practiced daytraders to earn a living.
2) When MMs are discussing The 10¢ shares with remaining need to be sold they are generally referring to shares purchased by the public for less than 10¢ not dilution.
3) The increasing trackability of individually owned shares & their price statistics severely disadvantage already marginalized public common stockholders who are loathe to give up trading versatility in exchange for the disutility of taking possession of their stock certificates. Trading houses can profit in multiple ways from this data without violating user privacy rights.
July revenue announcement is expected at any moment. What reasonable number do any of you see as being a real catalyst to positive SP action?
Looking forward to learning about EVOSS road performance capacities & battery recharging rate that are engineered by specific IQST technological innovations.
Most 125cc bikes can be aesthetic marvels.
Does the $800,000 revision upward of preliminary Q2 revenue numbers indicate that June revenue is actually $5.93 million and not $5.13 million as implied by the initial Q2 report & April/May press releases on revenue?
What effect did the perception of a pullback in month to month revenue for June have on stock price momentum? If the month to month revenue growth continuum is indeed unbroken does this mean July 2021 revenue will exceed $6 million?
I am sure we will here more about AGO-Bank once it has fulfilled all depository regulatory requirements of the Federal Reserve System. Don't expect the website to be fully functional until all of those Ps & Qs have been aligned (otherwise it is criminal fraud). I am betting the AGO-Bank family is completely online by October 1st and its partnership with IQST fully consummated. I am certain AGO-Bank already has 10000 agents contracted under a network service agreement with tentacles into almost all small market convenience stores (ATMs & digital advertising are everywhere now & so are retail clerks who accept prepaid-deposits, sell/lease prepaid mobile services (& other consumer products), & conduct wire transfers & other cash services)
Form 253 establishing the Fixed Price of share offering is prognosticated to occur after Q2 financials are reported. Q1 to Q2 revenue growth plus significant cost savings created by Telecom consolidation during Q1 will highlight the profitability achievement.
In addition, I would not be surprised to see a major news announcement giving impetus to positive share price action heading into the week Q2 is reported.
Q2 Net Profit for IQST is more deliciously likely (or so the offering inherently implies)
Notice of Effectiveness wait has begun
Q2 Net Profit depends upon Q1 Telecom cost consolidation of Etelix, Swiss Link, & QGlobal under Etelix (Are IQST tweets giving special emphasis to Etelix?).
Preliminary $15.5m Q2 revenues likely = Net Profit
14.2m Q1 revenues produced a gross profit of almost $500,000. If revenue costs remained the same during Q2 or improved and the company is no longer burdened by debt & interest expenses then Net Profit will be realized and announced the Second week of August.
Ambassadors, Let's spread the word, IQST financials will once again show growth and progress!
New MNPA telecom clients announcements expected at anytime.
Garbage posters will act in concert to bury the comments I have made with more examples of their inadequacies.
All of the shares being registered for sale by the Company under this Amendment will be sold at a fixed price, which will be within a range of $0.50 to $2.00 per share, established at qualification for the duration of the offering pursuant to Rule 253(b). https://www.sec.gov/Archives/edgar/data/1527702/000107878221000666/fa1offering_1a.htm
June Earnings release likely Monday july 19th or Tuesday July 20th
The short sellers have outed themselves by posting disinformation & grossly fellating each others commentaries as if they were something other than unwashable garbage. In so doing, they are intentionally poisoning the marginal utility of this board.
Some of us are expecting IQST to make BaaS contracts with other carriers for MNPA to firm up its asset valuation contribution and, furthermore, legitimize the revenue promise of ITsBChain. (there must be ongoing & substantive background developments to support company confidence in its $2 public offering)
It is my cost analysis for total bike manufacturing purchasable with $250,000 of proceeds from RevoltToken sales. It presumes that Modus received full payment for design costs from proceeds obtained from the sale of common shares & that IQST received partial payment for its engineering contributions with obtained shared IP rights. It furthermore assumes that the June 23th Press Release establishes an approximate time frame for the start of bike production that is highlighted by the 185,000 RevoltToken sale on June 25th and presumed time costs delays for shipping (10 bikes produced /day from june 30th-july 9th at a cost of $1500/ bike partially assembled in India & completed in Nairobi, Kenya *tax mitigation)
Rollout will only be hampered by manufacturing constraints, especially chip shortages & lithium/ precious metal prices
Because IQST isn't selling their bike in North America its MSRP will be much lower because it will not reflect USMCA nor U.S. regulations. I expect the required down payment to cover manufacturing costs and for the remaining loan balance to be sold as a CDO by an investment bank. Besides forging relations with LATAM retailers, I'd expect the banking representatives of IQST to expand the reach of its financing options through Global Money One & Maximo by likewise establishing local banking relations to increase financing offerings for eVoss [Let us hope no one is sitting on their twittling thumbs when phenomenal growth is within sight]
Principles of Capacity Requirement Planning for the contracted motorcycle assembly line & Cost Optimization for parts & tech suggest that it is reasonable to expect 100 Alternet Systems sourced bikes in total to enter the Nairobi, Kenya *4.5 million people & its stable electric grid* market during July for both the Boda Boda pilot program & the self-drive market. CRP & cost optimizations furthermore suggest that bikes dedicated to the self-drive market will significantly outnumber those dedicated to the Boda Boda market before the end of the pilot program
6. What are the criteria for determining whether a patent for a human drug product is eligible for patent extension? FDA.org
The term of a patent which claims a human drug product, a method of using the product or a method of manufacturing the product will be extended from the original expiration date if it satisfies six conditions.
First, the applicant must show that the patent has not expired.
Second, the applicant must establish that the patent has not previously been extended.
Third, the patent owner or its agent must submit an application for patent term restoration that includes details about the patent and the activities undertaken to secure FDA approval.
Fourth, the applicant must establish the product was subject to a regulatory review period before its commercial marketing or use.
Fifth, the applicant must show that the product either represents the first permitted commercial marketing or use of the product after such regulatory review period or, in the case of a product manufactured under a process patent that primarily uses recombinant deoxribonucleic acid (DNA) technology, represents the first permitted commercial marketing or use of a product manufactured under the process claimed in the patent.
Finally, the applicant must submit the application for patent term restoration to PTO within 60 days of FDA approval of the commercial marketing application.
eVoss & Modus Prototype
It looks like the Modus prototype has undergone substantial ergonomic design improvements. If Alternet Systems follows up with quick updates on its contracted deliveries & charging dock installations, it would seque market legitimacy for expected announcements of marketing agreements with retailers necessary for meaningful market penetration.
Where are the new hires needed to add teeth to that shareholder letter? My 14.95 average cost shares which had been parasailing are now completely submerged.
Why doesn't the fortune 500 company acknowledge IQST's planned role in their cost saving efforts?
Is IQST so oversold on the concept of clean energy that they are willing to hide the full details of their technical skills from indifferent capital investors?
Shouldn't institutional investors have sophisticated trading analytics tools at their fingertips to enable them to set ranges for trading parameters that will more than amply maintain the solvency of their investments?
BTW, holding down share prices for 7 unsavvy Institutional Investors in order to scare off significant longterm private stakeholders is a strategically unsound path to capture sustained investments from the necessary more than 20 institutions needed for price stability & inexpensive capital formation when value accretion is prerequisite.
July 1st only equals blinded to data. It innocuously symbolizes a 1/2 calendar year.
Some of us wanted more buying coerced on Friday to enable index recalibration to add greater price stability while the wait continues.
We are speaking at cross-purposes. The limited number of this board's readers will see the differences between our objectives & chuckle over the fruitless pedantry.
Employee stock options aren't FREE. They have a contracted purchase price for common shares. CVM employee options are generally only valuable if data is good. While it is possible that some employee options will be exercised on same-day sales, it is far more likely that they will simply wait for the buyout
Why are you pushing the narrative that employees will be spending money? We are dealing with the market situation for CVM. Employees have not exercised their options prior to data release and are unlikely to risk their money on uncertain results. If data is good, the company will be bought out + cash. If data is bad, options will be worthless. There is only one condition where the price of options is relevant to employees and that condition is if the phase III data is perfectly in the middle of expectations so as to somehow keep the share price from immediately collapsing below the cost of the cheapest options & remaining moribund until an inevitable buyout coinciding with the FDA drug approval panel recommendation.
I gave no consideration to better-than nothing same-day sales , because they are less ideal than the buyout plus cash option for CVM market expectations. Do let all of us know if, during the company's long history, an employee has relied upon a brokerage loan to capture a few thousand dollars from such a sale.
Buyout Plus Cash funds the exercise of employee options. Employees are responsible for the taxable income on the exercise price & capital gains on the exercised options from the buyout price.
Normally if there is never a buyout, few, if any, employee options are exercised because of the cost.
The price of employee options are made irrelevant by the widely expected buyout plus cash event (the cash pays for the options). Beneficiaries of exercised options at higher prices will have reduced capital gains exposure than for the cheaper (older) options.
{Update] Are these 3 job postings new
1) Facilities/Maintenance Administrator | CEL-SCI https://cel-sci.com/jobs/facilities-maintenance-administrator/
2) Quality Assurance Document Control (QA/DC) Assistant I Quality Assurance Document Control (QA/DC) Assistant I
3) Validation Supervisor | CEL-SCI
https://cel-sci.com/jobs/validation-supervisor/
if so, does this mean 4 positions were filled late last week?
Has anyone else detected a 10 business day pattern between OCTQB certification & the uplist date?